Clinical trials
Withdrawn Endometrial Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2019 | 1 |
| 2021 | 3 |
| 2023 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of New Mexico | 2 |
| Brown University | 1 |
| Case Comprehensive Cancer Center | 1 |
| City of Hope Medical Center | 1 |
| Genzyme, a Sanofi Company | 1 |
| HonorHealth Research Institute | 1 |
| Novartis Pharmaceuticals | 1 |
| QuantumLeap Healthcare Collaborative | 1 |
| Rutgers, The State University of New Jersey | 1 |
| The Cleveland Clinic | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endometrial Neoplasms | 14 |
| Ovarian Neoplasms | 3 |
| Neoplasms | 2 |
| Triple Negative Breast Neoplasms | 2 |
| Urinary Bladder Neoplasms | 2 |
| Uterine Cervical Neoplasms | 2 |
| Uterine Neoplasms | 2 |
| Vaginal Neoplasms | 2 |
| Agnosia | 1 |
| Breast Neoplasms | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.